循環器ジャーナル66巻3号

2018年07月発行

特集 肺高血圧症Cutting Edge Ⅳ．肺高血圧症治療：内科的治療と外科的治療，そして将来の治療

慢性血栓塞栓性肺高血圧症に対するバルーン肺動脈形成術と肺動脈血栓内膜摘除術—どのような患者が対象か，それぞれのベネフィットとリスクは？

著者： 田渕勲¹ 松原広己¹

所属機関： ¹独立行政法人国立病院機構岡山医療センター循環器科

ページ範囲：P.418 - P.425

Point
・肺動脈血栓内膜摘除術（PEA）の適応にならないすべての症例がバルーン肺動脈形成術（BPA）の適応となりうる．
・PEA，BPAどちらの治療法も長所・短所があり，一つの治療法に固執せずに適切な選択をすることが必要である．
・BPAは，単に血管病変を治療するのが目的ではなく肺高血圧症という特異な病態の治療を目的とする手技であり，未だに合併症を完全に防げるようになったわけではなく時に致死的な合併症を来す危険性があることから，誰でもが試みるべき手技ではない．

参考文献

1) Moser KM, Auger WR, Fedullo PF, et al:Chronic thromboembolic pulmonary hypertension:clinical picture and surgical treatment. Eur Respir J 5:334-342, 1992

2) 呼吸器系疾患調査研究班：難治性呼吸器疾患・肺高血圧症に関する調査研究．http://irdph.jp

3) Voorburg JA, Cats VM, Buis B, et al:Balloon angioplasty in the treatment of pulmonary hypertension caused by pulmonary embolism. Chest 94:1249-1253, 1988

4) Feinstein JA, Goldhaber SZ, Lock JE:et al:Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension. Circulation 103:10-13, 2001

5) Mizoguchi H, Ogawa A, Munemasa M, et al. Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension. Circ Cardiovasc Interv 5:748-755, 2012

6) Riedel M, Stanek V, Widimsky J, et al:Longterm follow-up of patients with pulmonary thromboembolism. Late prognosis and evolution of hemodynamic and respiratory data. Chest 81:151-158, 1982

7) Jamieson SW, Auger WR, Fedullo PF, et al:Experience and results with 150 pulmonary thromboendarterectomy operations over a 29-month period. J Thorac Cardiovasc Surg 106:116-126;discussion 126-127, 1993

8) Jamieson SW, Kapelanski DP, Sakakibara N, et al:Pulmonary endarterectomy:experience and lessons learned in 1, 500 cases. Ann Thorac Surg 76:1457-1462;discussion 1462-1464, 2003

9) 慢性肺動脈血栓塞栓症に対するballoon pulmonary angioplastyの適応と実施法に関するステートメント（2011-2013年度合同研究班報告）．2014

10) Thistlethwaite PA, Mo M, Madani MM, et al:Operative classification of thromboembolic disease determines outcome after pulmonary endarterectomy. J Thorac Cardiovasc Surg 124:1203-1211, 2002

11) Jenkins D, Madani M, Fadel E, et al:Pulmonary endarterectomy in the management of chronic thromboembolic pulmonary hypertension. Eur Respir Rev 26:160111, 2017

12) Freed DH, Thomson BM, Berman M, et al:Survival after pulmonary thromboendarterectomy:effect of residual pulmonary hypertension. J Thorac Cardiovasc Surg 141:383-387, 2011

13) Tanabe N, Sugiura T, Tatsumi K:Recent progress in diagnosis and management of chronic thromboembolic pulmonary hypertension. Respir Invest 51:134-146, 2013

14) Mayer E, Jenkins D, Lindner J, et al:Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension:results from an international prospective registry. J Thorac Cardiovasc Surg 141:702-710, 2011

15) Thistlethwaite PA, Kaneko K, Madani MM, et al:Technique and outcomes of pulmonary endarterectomy surgery. Ann Thorac Cardiovasc Surg 14:274-282, 2008

16) Bonderman D, Skoro-Sajer N, Jakowitsch J, et al:Predictors of outcome in chronic thromboembolic pulmonary hypertension. Circulation 115:2153-2158, 2007

17) 安藤太三，山下　満，佐藤雅人，他：慢性肺血栓塞栓症の外科治療．日外会誌106:252-257, 2005

18) 安藤太三：末梢型慢性肺血栓塞栓症に対する血栓内膜摘除術．呼と循60:39-48, 2012

19) Delcroix M, Lang I, Pepke-Zaba J, et al:Long-term outcome of patients with chronic thromboembolic pulmonary hypertension（CTEPH):results from an international prospective registry. Circulation 133:859-871, 2016

20) Miwa H, Tanabe N, Jujo T, et al:Long-Term Outcome of Chronic Thromboembolic Pulmonary Hypertension at a Single Japanese Pulmonary Endarterectomy Center. Circ J 82:1428-1436, 2018

21) Ghofrani HA, D' Armini AM, Grimminger F, et al:Riociguat for the treatment of chronic thromboembolic pulmonary hypertension. N Engl J Med 369:319-329, 2013

22) Kim NH, Delcroix M, Jenkins DP, et al:Chronic thromboembolic pulmonary hypertention. J Am Coll Cardiol 62（25 Supple):D92-D99, 2013

23) Lang IM, Madani M:Update on chronic thromboembolic pulmonary hypertention. Circulation 130:508-518, 2014